New target discovered for treatment of cancer

Jan 11, 2010

Researchers at the Swedish medical university Karolinska Institutet have discovered a new way of blocking the formation of blood vessels and halting the growth of tumours in mice. A substance that exploits this mechanism could be developed into a new treatment for cancer.

For a cancer to be able to grow larger than the size of a pea, the need to stimulate the formation of new that can supply the tumour with oxygen and nutrients, a process known as angiogenesis. A number of medicines which inhibit angiogenesis have been developed, but their effect has been limited, and there is still a major need for better medicines.

The new results concern a receptor on the surface of called ALK1. When the researchers blocked ALK1 in tumours in mice, angiogenesis was inhibited and the tumours stopped growing. The ALK1 receptor is activated by a family of signalling proteins called TGF-β proteins that are very important for communication between different types of cell in a wide range of key processes in the body. The study indicates that two members of the TGF-β family (TGF-β and BMP9) work together to stimulate angiogenesis in tumours.

ALK1 was blocked partly by genetic means and partly using a pharmaceutical substance called RAP-041.

"We believe that RAP-041 could be used in combination with existing angiogenesis inhibitors to achieve the maximum effect," says associate professor Kristian Pietras, who led the study.

Clinical studies of ACE-041, the human equivalent of RAP-041, have already been begun in the USA by the company that holds the patent on the substance. One goal of these studies is to find out which types of tumour are most sensitive to ALK1 blockade.

Explore further: Scientists learn more about rare skin cancer that killed Bob Marley

More information: 'Genetic and Pharmacological Targeting of Activin Receptor-like Kinase 1 Impairs Tumor Growth and Angiogenesis', Sara Cunha, Evangelia Pardali, Midory Thorikay, Charlotte Anderberg, Lukas Hawinkels, Marie-José Goumans, Jasbir Seehra, Carl-Henrik Heldin, Peterten Dijke, Kristian Pietras, The Journal of Experimental Medicine, online 11 January 2010.

add to favorites email to friend print save as pdf

Related Stories

Innovative method to starve tumors

Feb 11, 2009

The development of cancerous tumours is highly dependent on the nutrients the tumours receive through the blood. The team of Dr. Janusz Rak, of the Research Institute of the McGill University Health Centre (MUHC) at the Montreal ...

Socking it to cancer

Aug 02, 2006

An Australian research team has identified a gene that could be used to stop tumours growing by blocking their blood supply.

More blood vessels in hormone-resistant prostate tumors

Dec 15, 2009

Patients with advanced prostate cancer are often treated with hormones, but when the tumours start growing again they have more and different blood vessels, reveals a thesis from the Sahlgrenska Academy, at the University ...

Recommended for you

Understanding your kidney tumor in 3D

7 hours ago

Most patients rely on their doctors to decipher the black, white and gray images on their CT scans. But what if a patient could instead hold a 3D model made from the CT image in his hands? Suddenly, the picture ...

User comments : 0